Methyl 3-oxo-5-[2-(2-pyridin-3-yl-1,3-thiazol-4-yl)ethyl]-2H-pyrazolo[4,3-c]pyridine-7-carboxylate
C18H15N5O3S — CID 121238968
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 3-oxo-5-[2-(2-pyridin-3-yl-1,3-thiazol-4-yl)ethyl]-2H-pyrazolo[4,3-c]pyridine-7-carboxylate
Methyl 3-oxo-5-[2-(2-pyridin-3-yl-1,3-thiazol-4-yl)ethyl]-2H-pyrazolo[4,3-c]pyridine-7-carboxylate (PubChem CID 121238968) has the molecular formula C18H15N5O3S and a molecular weight of 381.42 g/mol. Its IUPAC name is methyl 3-oxo-5-[2-(2-pyridin-3-yl-1,3-thiazol-4-yl)ethyl]-2H-pyrazolo[4,3-c]pyridine-7-carboxylate.
Molecular Properties
| Compound Name | Methyl 3-oxo-5-[2-(2-pyridin-3-yl-1,3-thiazol-4-yl)ethyl]-2H-pyrazolo[4,3-c]pyridine-7-carboxylate |
|---|---|
| PubChem CID | 121238968 |
| Molecular Formula | C18H15N5O3S |
| Molecular Weight | 381.42 g/mol |
| Exact Mass | 381.09 |
| IUPAC Name | methyl 3-oxo-5-[2-(2-pyridin-3-yl-1,3-thiazol-4-yl)ethyl]-2H-pyrazolo[4,3-c]pyridine-7-carboxylate |
| SMILES | COC(=O)c1cn(CCc2csc(-c3cccnc3)n2)cc2c(=O)[nH]nc1-2 |
| InChI | InChI=1S/C18H15N5O3S/c1-26-18(25)14-9-23(8-13-15(14)21-22-16(13)24)6-4-12-10-27-17(20-12)11-3-2-5-19-7-11/h2-3,5,7-10H,4,6H2,1H3,(H,22,24) |
| InChIKey | SNFBNBZGPUXBHM-UHFFFAOYSA-N |
| XLogP | 2.22 |
| TPSA | 102.76 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 381.42 |
| LogP ≤ 5 | 2.22 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121238968 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.